JP2012527424A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012527424A5 JP2012527424A5 JP2012511265A JP2012511265A JP2012527424A5 JP 2012527424 A5 JP2012527424 A5 JP 2012527424A5 JP 2012511265 A JP2012511265 A JP 2012511265A JP 2012511265 A JP2012511265 A JP 2012511265A JP 2012527424 A5 JP2012527424 A5 JP 2012527424A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- day
- treating
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 241000209094 Oryza Species 0.000 claims 4
- 235000007164 Oryza sativa Nutrition 0.000 claims 4
- 235000009566 rice Nutrition 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 2
- 201000002980 Hyperparathyroidism Diseases 0.000 claims 2
- 201000004681 Psoriasis Diseases 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 201000006417 multiple sclerosis Diseases 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 208000001132 Osteoporosis Diseases 0.000 claims 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 230000003262 anti-osteoporosis Effects 0.000 claims 1
- 230000001028 anti-proliverative effect Effects 0.000 claims 1
- 230000002682 anti-psoriatic effect Effects 0.000 claims 1
- 239000013059 antihormonal agent Substances 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 208000005368 osteomalacia Diseases 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17990609P | 2009-05-20 | 2009-05-20 | |
| US61/179,906 | 2009-05-20 | ||
| PCT/EP2010/056832 WO2010145903A1 (en) | 2009-05-20 | 2010-05-18 | New therapeutical uses of inecalcitol |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016115489A Division JP2016179994A (ja) | 2009-05-20 | 2016-06-09 | イネカルシトールの新しい治療的使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012527424A JP2012527424A (ja) | 2012-11-08 |
| JP2012527424A5 true JP2012527424A5 (enExample) | 2013-07-04 |
Family
ID=42308305
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012511265A Pending JP2012527424A (ja) | 2009-05-20 | 2010-05-18 | イネカルシトールの新しい治療的使用 |
| JP2016115489A Pending JP2016179994A (ja) | 2009-05-20 | 2016-06-09 | イネカルシトールの新しい治療的使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016115489A Pending JP2016179994A (ja) | 2009-05-20 | 2016-06-09 | イネカルシトールの新しい治療的使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US8481514B2 (enExample) |
| EP (1) | EP2263677B1 (enExample) |
| JP (2) | JP2012527424A (enExample) |
| KR (1) | KR101845320B1 (enExample) |
| CN (1) | CN102448466A (enExample) |
| AT (1) | ATE505194T1 (enExample) |
| AU (1) | AU2010261967B2 (enExample) |
| BR (1) | BRPI1009056A2 (enExample) |
| CA (1) | CA2762458C (enExample) |
| DE (1) | DE602010000019D1 (enExample) |
| DK (1) | DK2263677T3 (enExample) |
| ES (1) | ES2363070T3 (enExample) |
| HR (1) | HRP20110433T1 (enExample) |
| IL (1) | IL216418A (enExample) |
| MX (1) | MX2011012330A (enExample) |
| NZ (1) | NZ596497A (enExample) |
| PL (1) | PL2263677T3 (enExample) |
| PT (1) | PT2263677E (enExample) |
| RU (1) | RU2571490C2 (enExample) |
| SG (1) | SG176581A1 (enExample) |
| SI (1) | SI2263677T1 (enExample) |
| UA (1) | UA105792C2 (enExample) |
| WO (1) | WO2010145903A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2360145T3 (pl) | 2010-01-26 | 2012-08-31 | Hybrigenics Sa | Nowy sposób izomeryzacji skondensowanych struktur bicyklicznych oraz wytwarzania zawierających te struktury analogów witaminy D |
| EP2407152A1 (en) * | 2010-07-15 | 2012-01-18 | Hybrigenics S.A. | Formulations of 14-epi-analogues of vitamin D |
| SI2407155T1 (sl) * | 2010-07-15 | 2013-04-30 | Hybrigenics S.A. | Preparati na osnovi inekalcitola |
| US20120015913A1 (en) | 2010-07-15 | 2012-01-19 | Delansorne Remi | Formulations of 14-EPI-Analogues of Vitamin D |
| US10111896B2 (en) | 2014-06-19 | 2018-10-30 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Composition comprising a combination of DNA methylation inhibitor and a vitamin D receptor agonist for the treatment of drug resistant cancer or for the prevention of tumor relapse |
| IL262565B (en) | 2016-06-06 | 2022-08-01 | Celgene Corp | Treatment of a hematologic malignancy with 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide |
| JP2020143008A (ja) * | 2019-03-05 | 2020-09-10 | 達也 楠堂 | 新規褐色脂肪細胞分化誘導剤 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0707566T3 (da) | 1993-07-09 | 2000-09-04 | Theramex | Hidtil ukendte strukturelle analoger til vitamin D |
| US6242434B1 (en) * | 1997-08-08 | 2001-06-05 | Bone Care International, Inc. | 24-hydroxyvitamin D, analogs and uses thereof |
| GB0305332D0 (en) * | 2003-03-10 | 2003-04-09 | Leuven K U Res & Dev | Biological evaluation of novel vitamin D analogues |
| JP2008514621A (ja) * | 2004-09-24 | 2008-05-08 | ビオクセル エッセ ピ ア | ２０−シクロアルキル，２６，２７−アルキル／ハロアルキル−ビタミンｄ３化合物及びその使用方法 |
-
2010
- 2010-05-18 BR BRPI1009056-8A patent/BRPI1009056A2/pt not_active Application Discontinuation
- 2010-05-18 DK DK10163156.2T patent/DK2263677T3/da active
- 2010-05-18 PL PL10163156T patent/PL2263677T3/pl unknown
- 2010-05-18 UA UAA201113630A patent/UA105792C2/uk unknown
- 2010-05-18 CN CN2010800222064A patent/CN102448466A/zh active Pending
- 2010-05-18 DE DE602010000019T patent/DE602010000019D1/de active Active
- 2010-05-18 AU AU2010261967A patent/AU2010261967B2/en not_active Ceased
- 2010-05-18 US US12/782,301 patent/US8481514B2/en not_active Expired - Fee Related
- 2010-05-18 CA CA2762458A patent/CA2762458C/en not_active Expired - Fee Related
- 2010-05-18 RU RU2011151854/15A patent/RU2571490C2/ru not_active IP Right Cessation
- 2010-05-18 ES ES10163156T patent/ES2363070T3/es active Active
- 2010-05-18 SI SI201030002T patent/SI2263677T1/sl unknown
- 2010-05-18 KR KR1020117030464A patent/KR101845320B1/ko not_active Expired - Fee Related
- 2010-05-18 NZ NZ596497A patent/NZ596497A/xx not_active IP Right Cessation
- 2010-05-18 MX MX2011012330A patent/MX2011012330A/es active IP Right Grant
- 2010-05-18 EP EP10163156A patent/EP2263677B1/en active Active
- 2010-05-18 PT PT10163156T patent/PT2263677E/pt unknown
- 2010-05-18 JP JP2012511265A patent/JP2012527424A/ja active Pending
- 2010-05-18 AT AT10163156T patent/ATE505194T1/de active
- 2010-05-18 SG SG2011085776A patent/SG176581A1/en unknown
- 2010-05-18 WO PCT/EP2010/056832 patent/WO2010145903A1/en not_active Ceased
-
2011
- 2011-06-09 HR HR20110433T patent/HRP20110433T1/hr unknown
- 2011-11-17 IL IL216418A patent/IL216418A/en not_active IP Right Cessation
-
2016
- 2016-06-09 JP JP2016115489A patent/JP2016179994A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012527424A5 (enExample) | ||
| Zhang et al. | Remodeling tumor microenvironment with natural products to overcome drug resistance | |
| Fauzee et al. | Taxanes: promising anti-cancer drugs | |
| JP2022180461A5 (enExample) | ||
| JP2014515373A5 (enExample) | ||
| JP2009541348A5 (enExample) | ||
| JP2012522837A5 (enExample) | ||
| RU2011151854A (ru) | Новые терапевтические способы применения инекальцитола | |
| Xue et al. | Curcumin as a multidrug resistance modulator—A quick review | |
| JP5514123B2 (ja) | 卵巣癌を治療するための、パクリタキセルを含む配合剤 | |
| SG175895A1 (en) | Antitumor combination including ave8062 and sorafenib | |
| Sharma et al. | Silymarin: a promising modulator of apoptosis and survival signaling in cancer | |
| JP2016505050A5 (enExample) | ||
| JP2018506533A5 (enExample) | ||
| RU2012108144A (ru) | Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами | |
| HRP20130237T1 (hr) | Formulacije inekalcitola | |
| BRPI0715609A2 (pt) | Composto, uso de um composto, métodos para produzir um efeito antiproliferativo em um animal de sangue quente, e para tratar uma doença em um animal de sangue quente, e, composição farmacêutica | |
| CN111770924A (zh) | 用于治疗乳腺癌的雌激素受体降解剂 | |
| JP2011514354A (ja) | 血管新生阻害作用を示す抗腫瘍テルペノイド医薬組成物アビシリン | |
| JP2015510945A5 (enExample) | ||
| Shukla et al. | Role of Usnic acid and its derivatives in the management of cancer | |
| TWI771315B (zh) | 微小奈米化藥劑及其利用 | |
| McMurray et al. | STAT3 Signaling in Cancer: Small Molecule Intervention as Therapy? | |
| JP2019517572A5 (enExample) | ||
| Gleason et al. | Bifunctional Vitamin D Hybrid Molecules |